SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Small Cap Foreign Biotech
An SI Board Since January 2000
Posts SubjectMarks Bans
363 30 0
Emcee:  RWReeves Type:  Unmoderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
238Yes, a few minutes. Now not interested. Nevermind. Wilderkeokalani'nui-2/5/2002
237Has anyone spent any time digging into Keryx? Wilderkeokalani'nui-2/5/2002
236GlycoDesign Inc. Reports GD0039 Survival Data TORONTO, Jan. 22 /PRNewswire/ - Gnigel bates-1/22/2002
235Wednesday January 9, 11:14 am Eastern Time Press Release SOURCE: Procyon Biophthebeach-1/9/2002
234Attention Business Editors: Procyon Licenses U.S. Marketing Rights for Fibrostathebeach-1/4/2002
233Yeah, there goes one of my ideas for 'biotech stockpicking 2002'.... <nigel bates-12/29/2001
232Wheeties!!........ quote.yahoo.com A few days more like this, and the originalscaram(o)uche-12/28/2001
231Millennium In-Licenses Novel Oncology Program From Xenova CAMBRIDGE, Mass., andnigel bates-12/17/2001
230I might have sold too early again - and it wouldn't be the first time... ftnigel bates-12/7/2001
229By Mark Potter LONDON, Dec 6 (Reuters) - British biotech firm Protherics Plc (LSnigel bates-12/6/2001
228Re:Antisoma: Finally, the answer! thanks nigel. Message 15722146keokalani'nui-11/23/2001
227LONDON, Nov. 23 /PRNewswire/ -- Antisoma plc (LSE: ASM, NASD: ASOM), the UK-basenigel bates-11/23/2001
226Xenova Group plc - Cancer Research Update at EORTC/NCI AACR Symposium SLOUGH, Enigel bates-10/31/2001
225Hi Wilder, I got out of Acambis a few days ago (too early, as usual), since on nigel bates-10/26/2001
224Nigel, re acambis American Home Products Submits Plan to Produce Smallpox Vaccikeokalani'nui-10/26/2001
223Chuckle. (eom)scaram(o)uche-10/15/2001
222HUMBLE: The for-some-people-short-lived feeling you get driving fast but withinkeokalani'nui-10/15/2001
221Humble? What is "humble"?scaram(o)uche-10/15/2001
220I am interested in Cyclacel, which is likely a early float candidate when the ukkeokalani'nui-10/15/2001
219A major focus on research at Amgen a few years ago. In the event that you'rscaram(o)uche-10/15/2001
218Cyclacel Provides Clinical Development Update on CYC202 CDK Inhibitor DUNDEE, Sckeokalani'nui-10/15/2001
217SLOUGH, England, Oct. 10 /PRNewswire/ -- Xenova Group plc (Nasdaq: XNVA; London nigel bates-10/10/2001
216Acambis: Successful Phase II Challenge Trial of ChimeriVax-JE Vaccine CAMBRIDGEnigel bates-9/20/2001
215CAMBRIDGE, UK, Sept. 20, 2001 (PRIMEZONE) -- Acambis plc (``Acambis'') (nigel bates-9/20/2001
214Try de.finance.yahoo.com Best, KarlKarl L.-9/17/2001
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News